1. Home
  2. SUNS vs XGN Comparison

SUNS vs XGN Comparison

Compare SUNS & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$6.96

Market Cap

108.7M

Sector

Real Estate

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

SELL

Current Price

$8.51

Market Cap

110.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SUNS
XGN
Founded
2023
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.7M
110.7M
IPO Year
2024
2014

Fundamental Metrics

Financial Performance
Metric
SUNS
XGN
Price
$6.96
$8.51
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$10.25
★ $10.57
AVG Volume (30 Days)
79.8K
★ 331.1K
Earning Date
11-10-2026
11-10-2026
Dividend Yield
★ 17.86%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.54
N/A
Revenue
★ $21,571,434.00
N/A
Revenue This Year
$91.54
$11.02
Revenue Next Year
$12.74
$10.28
P/E Ratio
$12.43
★ N/A
Revenue Growth
★ 102.96
N/A
52 Week Low
$5.77
$2.59
52 Week High
$10.45
$10.83

Technical Indicators

Market Signals
Indicator
SUNS
XGN
Relative Strength Index (RSI) 54.43 54.61
Support Level $6.20 $7.81
Resistance Level $7.90 $8.94
Average True Range (ATR) 0.27 0.54
MACD 0.09 0.05
Stochastic Oscillator 80.00 70.49

Price Performance

Historical Comparison
SUNS
XGN

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS, and debt-like preferred equity securities across CRE asset classes and investment mix to include high-quality multi-family, condominiums, retail, office, hospitality, industrial, mixed-use, and specialty-use real estate. The company's portfolio is concentrated in the Southern U.S.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: